Clinical Trials Browser

Lymphoma, Non-Hodgkin × Immunotherapy, Adoptive × 30 days × Clear all

NCT03434769 2026-02-27

AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Non Hodgkin Lymphoma

Phase 1 Active not recruiting

Lymphoma, Non-Hodgkin